Document Detail


Integrin Beta-4 expression in colorectal-cancer.
MedLine Citation:
PMID:  21559615     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Integrin alpha 6 beta 4 plays an important role in the interaction of epithelia with basement membranes, and its expression appears to be profoundly altered during tumor progression. Using a quantitative immunochemical assay, we investigated the expression of the beta 4 subunit associated with alpha 6 in 25 primary carcinomas, and in matching normal mucosae. alpha 6 beta 4 was expressed in all the carcinoma and mucosa samples. The highest beta 4 levels were detected in tumors at high clinical stage (Dukes' stage C). Furthermore, beta 4 reactivity inversely correlated with the degree of differentiation. By immunohistochemistry,beta 4 expression was particularly strong in the epithelium lining the upper third of the crypts and the absorbing surface of normal mucosa. In villous adenomas, beta 4 immunostaining tended to be enhanced in the epithelium lining the outer surfaces of neoplastic villi, but only 5 of 8 samples tested scored positive. In carcinomas, beta 4 expression was detected in 18 of 21 samples tested, and was strongly influenced by the pattern of tumor growth and by the type and level of differentiation. Carcinomas, or areas of carcinomas, with cohesive and differentiated growth pattern demonstrated weak beta 4 expression at the tumor-stroma interface. Carcinoma cells at the lumenal surface of the intestine, and carcinomas, or areas of carcinomas, composed of small clusters of cells surrounded by stroma, demonstrated strong beta 4 expression. Altogether, our observations indicate that in colorectal tumors the expression of the beta 4 subunit is strongly influenced by microenvironmental factors and tends to increase in high stage, poorly differentiated lesions.
Authors:
R Falcioni; V Turchi; P Vitullo; G Navarra; F Ficari; F Cavaliere; A Sacchi; R Marianicostantini
Related Documents :
1356315 - Molecular basis of clinical heterogeneity in neuroblastoma.
8797595 - Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridi...
11464905 - Multicentre analysis of patterns of dna gains and losses in 204 neuroblastoma tumors: h...
15167935 - Cgh and cd 44/mib-1 immunohistochemistry are helpful to distinguish metastasized from n...
21630205 - Gingival granular cell tumor of the newborn: a case report and review of literature.
15770715 - Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, wh...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of oncology     Volume:  5     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  1994 Sep 
Date Detail:
Created Date:  2011-05-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  573-8     Citation Subset:  -    
Affiliation:
IST REGINA ELENA,CTR RIC SPERIMENTALE,ONCOGENESI MOLEC LAB,I-00158 ROME,ITALY. UNIV ROMA LA SAPIENZA,DIPARTIMENTO MED SPERIMENTALE,ROME,ITALY. UNIV FERRARA,IST CLIN CHIRURG,FERRARA,ITALY. UNIV FLORENCE,IST PATOL CHIRURG,FLORENCE,ITALY. UNIV G DANNUNZIO,IST PATOL UMANA,CHIETI,ITALY. IST REGINA ELENA,DIV CHIRURG 1,I-00158 ROME,ITALY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variable p-glycoprotein immunoreactivity unrelated to cytotoxic drug-resistance in-vitro of human ad...
Next Document:  Loss of heterozygosity and microsatellite instability of the h-ras gene in cancer of the head and ne...